SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-15-000012
Filing Date
2015-05-06
Accepted
2015-05-06 16:06:50
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q flks201533110-q.htm 10-Q 362983
2 EXHIBIT 31.1 flks2015331ex-311.htm EX-31.1 10211
3 EXHIBIT 31.2 flks2015331ex-312.htm EX-31.2 10245
4 EXHIBIT 32.1 flks2015331ex-321.htm EX-32.1 9211
  Complete submission text file 0001615219-15-000012.txt   2789904

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT flks-20150331.xml EX-101.INS 291815
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20150331.xsd EX-101.SCH 18849
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20150331_cal.xml EX-101.CAL 33326
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20150331_def.xml EX-101.DEF 109450
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20150331_lab.xml EX-101.LAB 291984
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20150331_pre.xml EX-101.PRE 173624
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 15836993
SIC: 2834 Pharmaceutical Preparations